In a murine model of experimental colitis induced by intrarectal administration of DNBS, the beneficial effect of adenosine deaminase inhibitors was abrogated in the presence of A2AR and A3R antagonists, suggesting a protective role for both receptors (46). The gene discussed is ADA; the disease is colitis.